Live feed
Filing
SC 13G/A
SC 13G/A0001678858-22-000232·Syndax Pharmaceuticals Inc
Schedule 13G ownership disclosure
Syndax Pharmaceuticals Inc
Security class unavailable · CUSIP: 87164F105
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,598,766
- Percent of class
- 3.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001678858-22-000232
- Form type
- SC 13G/A
- Filer
- Syndax Pharmaceuticals Inc
- CIK
- CIK 1395937
- Filed
- Feb 04, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership